These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12821045)

  • 21. Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits.
    Teschke R; Qiu SX; Lebot V
    Dig Liver Dis; 2011 Sep; 43(9):676-81. PubMed ID: 21377431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute hepatitis due to kava-kava and St John's Wort: an immune-mediated mechanism?].
    Musch E; Chrissafidou A; Malek M
    Dtsch Med Wochenschr; 2006 May; 131(21):1214-7. PubMed ID: 16721710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop.
    Thomsen M; Schmidt M
    J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.
    Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA
    Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion.
    Zou L; Harkey MR; Henderson GL
    Planta Med; 2005 Feb; 71(2):142-6. PubMed ID: 15729622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Kava-induced acute icteric hepatitis].
    Bujanda L; Palacios A; Silvariño R; Sánchez A; Muñoz C
    Gastroenterol Hepatol; 2002; 25(6):434-5. PubMed ID: 12069710
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapeutic potential of kava in the treatment of anxiety disorders.
    Singh YN; Singh NN
    CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Piper methysticum (kava) under discussion: observations on quality, effectiveness and safety].
    Schmidt M; Nahrstedt A; Lüpke NP
    Wien Med Wochenschr; 2002; 152(15-16):382-8. PubMed ID: 12244883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence.
    Teschke R; Qiu SX; Xuan TD; Lebot V
    Phytother Res; 2011 Sep; 25(9):1263-74. PubMed ID: 21442674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of ethanol in kava hepatotoxicity.
    Li XZ; Ramzan I
    Phytother Res; 2010 Apr; 24(4):475-80. PubMed ID: 19943335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kava--the unfolding story: report on a work-in-progress.
    Denham A; McIntyre M; Whitehouse J
    J Altern Complement Med; 2002 Jun; 8(3):237-63. PubMed ID: 12165183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
    Anke J; Ramzan I
    J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kava, the anxiolytic herb: back to basics to prevent liver injury?
    Teschke R; Sarris J; Glass X; Schulze J
    Br J Clin Pharmacol; 2011 Mar; 71(3):445-8. PubMed ID: 21284704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kava extracts: safety and risks including rare hepatotoxicity.
    Teschke R; Gaus W; Loew D
    Phytomedicine; 2003; 10(5):440-6. PubMed ID: 12834011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects.
    Sarris J; Stough C; Teschke R; Wahid ZT; Bousman CA; Murray G; Savage KM; Mouatt P; Ng C; Schweitzer I
    Phytother Res; 2013 Nov; 27(11):1723-8. PubMed ID: 23348842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Necrotizing hepatitis after taking herbal remedies].
    Strahl S; Ehret V; Dahm HH; Maier KP
    Dtsch Med Wochenschr; 1998 Nov; 123(47):1410-4. PubMed ID: 9856112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia.
    Russmann S; Barguil Y; Cabalion P; Kritsanida M; Duhet D; Lauterburg BH
    Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):1033-6. PubMed ID: 12923378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute liver failure after administration of herbal tranquilizer kava-kava (Piper methysticum).
    Brauer RB; Stangl M; Stewart JR; Pfab R; Becker K
    J Clin Psychiatry; 2003 Feb; 64(2):216-8. PubMed ID: 12633134
    [No Abstract]   [Full Text] [Related]  

  • 40. Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment.
    Teschke R; Fuchs J; Bahre R; Genthner A; Wolff A
    J Clin Pharm Ther; 2010 Oct; 35(5):545-63. PubMed ID: 20831679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.